CHC HEALTHCARE GROUP |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.8 TWD | -0.36% |
|
+0.36% | -8.67% |
| Mar. 14 | CHC Healthcare Group Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 13 | CHC Healthcare Group Proposes Dividend Distribution for the Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,944 | 6,128 | 7,035 | 10,146 | 9,357 | - |
| Enterprise Value (EV) 1 | 5,944 | 6,128 | 7,035 | 10,146 | 9,357 | 9,357 |
| P/E ratio | 20.3 x | 17.5 x | 22 x | 24 x | 16.4 x | 12.9 x |
| Yield | - | 5.28% | 4.62% | 3.29% | 4.87% | - |
| Capitalization / Revenue | - | 2.51 x | 2.37 x | 2.62 x | 2.16 x | - |
| EV / Revenue | - | 2.51 x | 2.37 x | 2.62 x | 2.16 x | - |
| EV / EBITDA | - | - | - | - | - | - |
| EV / FCF | - | 34.3 x | -271 x | 24.6 x | 17.9 x | - |
| FCF Yield | - | 2.92% | -0.37% | 4.07% | 5.58% | - |
| Price to Book | - | 1.01 x | 1.15 x | 1.57 x | 1.43 x | - |
| Nbr of stocks (in thousands) | 150,290 | 161,049 | 161,543 | 166,050 | 167,689 | - |
| Reference price 2 | 39.55 | 38.05 | 43.55 | 61.10 | 55.80 | 55.80 |
| Announcement Date | 3/18/21 | 3/23/22 | 3/23/23 | 3/14/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 2,440 | 2,974 | 3,877 | 4,336 | - |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | - | 493.3 | 475.8 | 613.5 | 778 | - |
| Operating Margin | - | 20.22% | 16% | 15.82% | 17.94% | - |
| Earnings before Tax (EBT) 1 | - | 491.1 | 483.8 | 559.4 | 722 | - |
| Net income 1 | 366.4 | 381.6 | 356.6 | 418.9 | 566 | 717 |
| Net margin | - | 15.64% | 11.99% | 10.8% | 13.05% | - |
| EPS 2 | 1.950 | 2.180 | 1.980 | 2.550 | 3.400 | 4.310 |
| Free Cash Flow 1 | - | 178.7 | -25.97 | 412.9 | 522 | - |
| FCF margin | - | 7.33% | -0.87% | 10.65% | 12.04% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | 46.83% | - | 98.58% | 92.23% | - |
| Dividend per Share 2 | - | 2.010 | 2.010 | 2.010 | 2.720 | - |
| Announcement Date | 3/18/21 | 3/23/22 | 3/23/23 | 3/14/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 479 | 876.6 | 606.2 | 692.2 | 817.5 | 858.5 | 800.3 | 886.2 | 737.7 | 1,453 | 710 | 935 | 1,070 | 1,620 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 121.2 | 156.9 | 99.24 | 98.11 | 153.9 | 124.5 | 116.9 | 149.5 | 80.77 | 266.3 | 84 | 142 | 212 | 340 |
| Operating Margin | 25.3% | 17.9% | 16.37% | 14.17% | 18.82% | 14.51% | 14.6% | 16.87% | 10.95% | 18.33% | 11.83% | 15.19% | 19.81% | 20.99% |
| Earnings before Tax (EBT) 1 | 86.82 | 173.3 | 103 | 130.2 | 137.6 | 113 | 109.2 | 132 | 60.38 | 257.9 | 70 | 128 | 198 | 326 |
| Net income 1 | 66.99 | 136.1 | 60.2 | 111.3 | 101.4 | 83.68 | 79.25 | 95.56 | 43.27 | 200.8 | 55 | 100 | 155 | 257 |
| Net margin | 13.99% | 15.53% | 9.93% | 16.08% | 12.4% | 9.75% | 9.9% | 10.78% | 5.87% | 13.82% | 7.75% | 10.7% | 14.49% | 15.86% |
| EPS 2 | 0.3900 | 0.7500 | 0.3400 | 0.6100 | 0.5600 | 0.4700 | 0.4900 | 0.5800 | 0.2600 | 1.220 | 0.3300 | 0.6000 | 0.9300 | 1.540 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/2/21 | 3/23/22 | 5/4/22 | 8/3/22 | 11/3/22 | 3/23/23 | 5/4/23 | 8/7/23 | 11/6/23 | 3/14/24 | - | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 179 | -26 | 413 | 522 | - |
| ROE (net income / shareholders' equity) | - | 6.4% | 5.83% | 6.65% | 6.88% | - |
| ROA (Net income/ Total Assets) | - | 3.17% | 2.81% | 3.17% | 3.63% | - |
| Assets 1 | - | 12,056 | 12,699 | 13,222 | 15,592 | - |
| Book Value Per Share 2 | - | 37.80 | 38.00 | 38.80 | 39.10 | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 514 | 683 | 550 | 500 | - |
| Capex / Sales | - | 21.07% | 22.95% | 14.18% | 11.53% | - |
| Announcement Date | 3/18/21 | 3/23/22 | 3/23/23 | 3/14/24 | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
55.8
TWD
Average target price
71
TWD
Spread / Average Target
+27.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.67% | 287M | |
| +13.93% | 198M | |
| +26.13% | 77.74M | |
| +20.48% | 65.76M |
- Stock Market
- Equities
- 4164 Stock
- Financials CHC Healthcare Group
